About the project
In EUGeneHeart 21 partners from 10 European countries build a scientific research consortium with focus on signalling mechanisms with respect to heart failure. EUGeneHeart is a EU funded integrated research project.
Read more about the project
Read more about publications
APEIRON Biologics AG (Apeiron) will announce at BioSquare 2010 in Geneva the closing of a multi-million Euro out-licensing deal with one of the world's top-5 pharmaceutical companies.
The fourth EUGeneHeart General Assembly in November 2009 in Utrecht / The Netherlands.
The EUGeneHeart consortium has organised a EUGeneHeart Seminar series, focusing on professional training in basic cardiovascular research.
All members of EUGeneHeart contracted labs can apply for a travel grant in the context of a training project proposed by the applicant and the host lab. This new application rule will be in force starting from 1 January 2009.
EUGeneHeart - European Excellence project for heart research
European Union promotes with 11,4 million Euros - coordination in Göttingen.
TOP OF SITE
PRINT
